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• HOLEP has the potential for cost 
savings by reducing the cost of 
hospitalization for patients undergoing 
surgical management of BPH
• Same day HOLEP does not sacrifice 
postoperative outcomes
• Future studies should include 
– Larger sample size
– Extended follow up of patients beyond 3-6 
months
– More detailed cost analysis between 
modalities
Cost Savings Achieved through Introduction of Holmium Laser 
Enucleation of the Prostate (HOLEP)
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outcomes in current literature that HOLEP is at worst 
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intervals
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Problem Statement
Benign Prostatic Hyperplasia 
(BPH)
• ↑incidence and prevalence 
worldwide
• 80% of men will experience BPH 
by their 8th decade of life 
• ↑risk of mortality, depression, 
falls
• ↓health-related quality-of-life 
• billions of $$$ in annual health 
expenditures
• When medical management fails, 
surgical treatment is warranted
The objective of this study is to compare B 
TURP and same-day HOLEP with respect 




























































3 month ∆ipss 
(decrease)
3 month ∆Qmax 
(inrease in ml/s)
6 month ∆ipss 
(decrease)
6 month ∆Qmax 
(increase in ml/s)
Postoperative Interval Changes
HOLEP mean B TURP mean
Demographics:
• 150 participants
• 100% male
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